Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia and gout.

Würzner G, Gerster JC, Chiolero A, Maillard M, Fallab-Stubi CL, Brunner HR, Burnier M.

J Hypertens. 2001 Oct;19(10):1855-60.

PMID:
11593107
2.

Comparative effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricemia and gout.

Liberopoulos E, Christides D, Elisaf M.

J Hypertens. 2002 Feb;20(2):347. No abstract available.

PMID:
11821722
3.

Effects of losartan and irbesartan on serum uric acid in hypertensive patients with hyperuricaemia in Chinese population.

Dang A, Zhang Y, Liu G, Chen G, Song W, Wang B.

J Hum Hypertens. 2006 Jan;20(1):45-50.

PMID:
16281062
4.

[The effects of angiotensin II receptor blockers in hypertensive patients complicating hyperuricaemia].

Dang AM, Liu GZ, Zhang YH, Chen GL; Intervening Uric Acid Study Group Investigators..

Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Oct;34(10):882-5. Chinese.

PMID:
17217711
5.

Effect of eprosartan and losartan on uric acid metabolism in patients with essential hypertension.

Puig JG, Mateos F, Buño A, Ortega R, Rodriguez F, Dal-Ré R.

J Hypertens. 1999 Jul;17(7):1033-9.

PMID:
10419078
6.
7.

Comparative efficacy of two angiotensin II receptor antagonists, irbesartan and losartan in mild-to-moderate hypertension. Irbesartan/Losartan Study Investigators.

Kassler-Taub K, Littlejohn T, Elliott W, Ruddy T, Adler E.

Am J Hypertens. 1998 Apr;11(4 Pt 1):445-53. Erratum in: Am J Hypertens 1998 Jun;11(6 Pt 1):736.

PMID:
9607383
8.

An elective-titration study of the comparative effectiveness of two angiotensin II-receptor blockers, irbesartan and losartan. Irbesartan/Losartan Study Investigators.

Oparil S, Guthrie R, Lewin AJ, Marbury T, Reilly K, Triscari J, Witcher JA.

Clin Ther. 1998 May-Jun;20(3):398-409.

PMID:
9663357
9.

Use of 24-hour ambulatory blood pressure monitoring to assess antihypertensive efficacy: a comparison of olmesartan medoxomil, losartan potassium, valsartan, and irbesartan.

Smith DH, Dubiel R, Jones M.

Am J Cardiovasc Drugs. 2005;5(1):41-50. Erratum in: Am J Cardiovasc Drugs. 2005;5(3):209.

PMID:
15631537
10.

Impact of irbesartan, an angiotensin receptor blocker, on uric acid level and oxidative stress in high-risk hypertension patients.

Chida R, Hisauchi I, Toyoda S, Kikuchi M, Komatsu T, Hori Y, Nakahara S, Sakai Y, Inoue T, Taguchi I.

Hypertens Res. 2015 Nov;38(11):765-9. doi: 10.1038/hr.2015.82.

PMID:
26178150
11.

Renal response to the angiotensin II receptor subtype 1 antagonist irbesartan versus enalapril in hypertensive patients.

Pechère-Bertschi A, Nussberger J, Decosterd L, Armagnac C, Sissmann J, Bouroudian M, Brunner HR, Burnier M.

J Hypertens. 1998 Mar;16(3):385-93.

PMID:
9557932
12.

A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).

Coca A, Calvo C, García-Puig J, Gil-Extremera B, Aguilera MT, de la Sierra A, Martín-Hidalgo A, Marín R; MAPAVEL Investigators (Monitorizacíon Ambulatoria Presión Arterial APROVEL)..

Clin Ther. 2002 Jan;24(1):126-38.

PMID:
11833827
14.
15.
16.

To study the efficacy of Losartan on urinary uric acid excretion in Thiazide induced hyperuricemic and hypertensive patients.

Khan M, Khan RA, Islam F, Laghari J, Jamali SN.

Pak J Pharm Sci. 2011 Oct;24(4):583-7.

PMID:
21959825
17.

Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.

Ruilope LM, Simpson RL, Toh J, Arcuri KE, Goldberg AI, Sweet CS.

Blood Press. 1996 Jan;5(1):32-40.

PMID:
8777471
18.

Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.

Gansevoort RT, de Zeeuw D, Shahinfar S, Redfield A, de Jong PE.

J Hypertens Suppl. 1994 Jul;12(2):S37-42.

PMID:
7965264
19.

[Irbesartan in hypertensive non-diabetic advanced chronic kidney disease. Comparative study with ACEI].

Coronel F, Cigarrán S, García-Mena M, Herrero JA, Calvo N, Pérez-Flores I.

Nefrologia. 2008;28(1):56-60. Spanish.

20.

Irbesartan: a review of its use in hypertension and in the management of diabetic nephropathy.

Croom KF, Curran MP, Goa KL, Perry CM.

Drugs. 2004;64(9):999-1028. Review.

PMID:
15101793

Supplemental Content

Support Center